Short Interest in Sonova Holding (OTCMKTS:SONVY) Declines By 57.5%

Sonova Holding (OTCMKTS:SONVY – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totaling 3,908 shares, a drop of 57.5% from the August 15th total of 9,201 shares. Based on an average daily trading volume, of 14,158 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Several research firms recently commented on SONVY. Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a research note on Tuesday, June 23rd. Citigroup reissued a “sell” rating on shares of Sonova in a report on Friday, July 24th. Finally, UBS Group raised shares of Sonova from a “hold” rating to a “buy” rating in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Sonova has a consensus rating of “Hold”.

Get Sonova alerts:

Read Our Latest Stock Analysis on Sonova

Sonova Stock Performance

Shares of Sonova stock opened at $55.54 on Monday. The company’s 50 day moving average price is $55.66 and its two-hundred day moving average price is $50.74. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75. Sonova has a fifty-two week low of $42.26 and a fifty-two week high of $61.04.

Sonova Company Profile

(Get Free Report)

Sonova Holding AG is a Switzerland-based company focused on hearing care and hearing solutions. Through its businesses, the company develops, manufactures and distributes hearing aids, cochlear implants and other hearing-related technologies designed to help people with hearing loss communicate and participate more fully in daily life.

Sonova’s portfolio includes hearing instruments and accessories, wireless communication products, implantable hearing systems and audiological services.

Further Reading

• Five stocks we like better than Sonova
• Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
• 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
• Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
• As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.